ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
Pulpfiction
|
5.8K |
1.4M |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
5.8K
|
1.4M
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
Pulpfiction
|
15 |
3.1K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
15
|
3.1K
|
0
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Positive data from ISLA-101 Single Ascending Dose study
|
|
Pulpfiction
|
16 |
3.0K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
16
|
3.0K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX100 Ph1b results to be presented at specialist congress
|
|
Pulpfiction
|
15 |
7.2K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
15
|
7.2K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria Expands Specialist AP Team - First Female for MDMA-AT
|
|
Pulpfiction
|
5 |
1.3K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
5
|
1.3K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification regarding unquoted securities - RAC
|
|
Pulpfiction
|
6 |
1.9K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
6
|
1.9K
|
2
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Results of Rights Issue Offer
|
|
Pulpfiction
|
21 |
4.2K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
21
|
4.2K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Pulpfiction
|
469 |
199K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
469
|
199K
|
0
|
|
ASX - By Stock
|
RTR |
Re:
Ann: Earaheedy Project Tenement Acquisition Completed
|
|
Pulpfiction
|
4 |
2.0K |
4 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4
|
2.0K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix to Present at Euroz Hartleys Conference
|
|
Pulpfiction
|
112 |
28K |
10 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
112
|
28K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
Pulpfiction
|
87 |
31K |
2 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
87
|
31K
|
2
|
|
ASX - By Stock
|
ILA |
Re:
Ann: $1.95million Fully Underwritten Rights Issue
|
|
Pulpfiction
|
22 |
5.2K |
1 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
22
|
5.2K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Pulpfiction
|
469 |
199K |
26 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
469
|
199K
|
26
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Pulpfiction
|
469 |
199K |
8 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
469
|
199K
|
8
|
|
ASX - By Stock
|
PCL |
Re:
General Thoughts
|
|
Pulpfiction
|
3.5K |
1.5M |
1 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
3.5K
|
1.5M
|
1
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Pulpfiction
|
5 |
1.3K |
4 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
5
|
1.3K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Webinar Presentation
|
|
Pulpfiction
|
14 |
3.8K |
3 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
14
|
3.8K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Pulpfiction
|
113 |
40K |
9 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
113
|
40K
|
9
|
|
ASX - By Stock
|
EMD |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
Pulpfiction
|
28 |
5.5K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
28
|
5.5K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
Pulpfiction
|
821 |
206K |
15 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
821
|
206K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
Pulpfiction
|
821 |
206K |
3 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
821
|
206K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: NDA Resubmission Accepted and Approval Date Confirmed
|
|
Pulpfiction
|
112 |
35K |
10 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
112
|
35K
|
10
|
|
ASX - By Stock
|
PCL |
Re:
Ann: PEL 87 Project Update
|
|
Pulpfiction
|
95 |
46K |
9 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
95
|
46K
|
9
|
|
ASX - By Stock
|
PCL |
Re:
Ann: PEL 87 Project Update
|
|
Pulpfiction
|
95 |
46K |
10 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
95
|
46K
|
10
|
|
ASX - By Stock
|
RTR |
Re:
Ann: Completion of Metallurgical Diamond Drilling at Earaheedy
|
|
Pulpfiction
|
4 |
2.7K |
9 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
4
|
2.7K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Resubmission of NDA for Sofdra Completed
|
|
Pulpfiction
|
108 |
27K |
11 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
108
|
27K
|
11
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 Ph1b results show excellent safety & efficacy in TCL
|
|
Pulpfiction
|
37 |
16K |
8 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
37
|
16K
|
8
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 Ph1b results show excellent safety & efficacy in TCL
|
|
Pulpfiction
|
37 |
16K |
13 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
37
|
16K
|
13
|
|
ASX - By Stock
|
ILA |
Re:
ILA - Media coverage
|
|
Pulpfiction
|
12 |
2.3K |
4 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
12
|
2.3K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Confirms Approach to Sofdra NDA Resubmission
|
|
Pulpfiction
|
81 |
21K |
7 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
81
|
21K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Confirms Approach to Sofdra NDA Resubmission
|
|
Pulpfiction
|
81 |
21K |
5 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
81
|
21K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Pulpfiction
|
8.0K |
2.9M |
10 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
8.0K
|
2.9M
|
10
|
|
ASX - By Stock
|
NC6 |
Re:
3 cents! Options are worthless. Where to now?
|
|
Pulpfiction
|
29 |
6.8K |
3 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
29
|
6.8K
|
3
|
|
ASX - By Stock
|
NC6 |
Re:
3 cents! Options are worthless. Where to now?
|
|
Pulpfiction
|
29 |
6.8K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
29
|
6.8K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Placement Secures $13.5M to Fund Sofdra Launch Prep
|
|
Pulpfiction
|
116 |
30K |
3 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
116
|
30K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Dr Daniel Tillett appointed CEO of Race Oncology
|
|
Pulpfiction
|
93 |
24K |
18 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
93
|
24K
|
18
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Placement & Security Purchase Plan
|
|
Pulpfiction
|
18 |
4.3K |
3 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
18
|
4.3K
|
3
|
|
ASX - By Stock
|
SOR |
Re:
Ann: SOR Reaches New Heights in Moisture-Based Energy
|
|
Pulpfiction
|
56 |
22K |
14 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
56
|
22K
|
14
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Pulpfiction
|
469 |
199K |
17 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
469
|
199K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Meets Quality Specifications
|
|
Pulpfiction
|
101 |
20K |
5 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
101
|
20K
|
5
|
|
ASX - By Stock
|
SOR |
Re:
Ann: SOR Quarterly Update and Appendix 4C
|
|
Pulpfiction
|
34 |
14K |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
34
|
14K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Ann: September 2023 Quarterly Update and Appendix 4C
|
|
Pulpfiction
|
26 |
7.8K |
5 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
26
|
7.8K
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: September 2023 Quarterly Activities Report and Appendix 4C
|
|
Pulpfiction
|
6 |
1.6K |
0 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
6
|
1.6K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX results to be presented at world's largest blood meeting
|
|
Pulpfiction
|
31 |
13K |
5 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
31
|
13K
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Letter to Shareholders - Notice of Annual General Meeting
|
|
Pulpfiction
|
8 |
1.8K |
3 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
8
|
1.8K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Pulpfiction
|
469 |
199K |
3 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
469
|
199K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria's Clinic Achieves Key MDMA-AT Dosing Milestone
|
|
Pulpfiction
|
6 |
1.6K |
2 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
6
|
1.6K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Toxicology and Safety Pharmacology Studies Initiated
|
|
Pulpfiction
|
42 |
14K |
10 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
42
|
14K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Toxicology and Safety Pharmacology Studies Initiated
|
|
Pulpfiction
|
42 |
14K |
4 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
42
|
14K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Toxicology and Safety Pharmacology Studies Initiated
|
|
Pulpfiction
|
42 |
14K |
5 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
42
|
14K
|
5
|
|